{"disease":{"id":"lou-gehrig-disease","name":"lou gehrig disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03868345","title":"Speech Analysis in ALS Patients","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Barrow Neurological Institute","has_results":false},{"nct_id":"NCT03520517","title":"Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06315608","title":"MRG-001 in Patients With Amyotrophic Lateral Sclerosis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"MedRegen LLC","has_results":false},{"nct_id":"NCT03537807","title":"Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}